A non-inferiority study of rituximab versus ocrelizumab in relapsing-remitting multiple sclerosis

I Roos, S Hughes, G MacDonnell, C Boz, R Alroughani, S Ozakbas, K Buzzard, O Skibina, A Van der Walt, H Butzkueven, J Lechner-Scott, J Kuhle, M Terzi, G Laureys, L Van Hijfte, N John, P Grammond, F Grand'Maison, A Soysal, F Sellebjerg Show all